DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Kruppel-Like Factor 4 Expression
Open Access
- 14 September 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 23 (18), 5585-5597
- https://doi.org/10.1158/1078-0432.CCR-17-0387
Abstract
Purpose: The dismal prognosis of pancreatic cancer has been linked to poor tumor differentiation. However, molecular basis of pancreatic cancer differentiation and potential therapeutic value of the underlying molecules remain unknown. We investigated the mechanistic underexpression of Kruppel-like factor 4 (KLF4) in pancreatic cancer and defined a novel epigenetic pathway of its activation for pancreatic cancer differentiation and treatment. Experimental Design: Expressions of KLF4 and DNMT1 in pancreatic cancer tissues were determined by IHC and the genetic and epigenetic alterations of KLF4 in and KLF4's impact on differentiation of pancreatic cancer were examined using molecular biology techniques. The function of dietary 3,3'-diindolylmethane (DIM) on miR-152/DNMT1/KLF4 signaling in pancreatic cancer was evaluated using both cell culture and animal models. Results: Overexpression of DNMT1 and promoter hyper-methylation contributed to decreased KLF4 expression in and associated with poor differentiation of pancreatic cancer. Manipulation of KLF4 expression significantly affected differentiation marker expressions in pancreatic cancer cells. DIM treatment significantly induced miR-152 expression, which blocked DNMT1 protein expression and its binding to KLF4 promoter region, and consequently reduced promoter DNA methylation and activated KLF4 expression in pancreatic cancer cells. In addition, DIM treatment caused significant inhibition of cell growth in vitro and tumorigenesis in animal models of pancreatic cancer. Conclusions: This is the first demonstration that dysregulated KLF4 expression associates with poor differentiation of pancreatic cancer. Epigenetic activation of miR-152/DNMT1/KLF4 signaling pathway by dietary DIM causes differentiation and significant growth inhibition of pancreatic cancer cells, highlighting its translational implications for pancreatic and other cancers. (C) 2017 AACR.Keywords
Other Versions
Funding Information
- NIH (R01CA172233, 1R01CA195651, and 1R01CA198090; and grants R03-CA124523)
- American Institute for Cancer Research University of Texas MD Anderson Cancer Center (#10A073)
This publication has 66 references indexed in Scilit:
- KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic CarcinogenesisCancer Cell, 2016
- MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA ExpressionPharmaceuticals, 2013
- KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal CarcinomaThe American Journal of Pathology, 2011
- Identification of Pancreatic Cancer Stem CellsCancer Research, 2007
- DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreasCarcinogenesis: Integrative Cancer Research, 2006
- Orthotopic Transplantation Models of Pancreatic Adenocarcinoma Derived From Cell Lines and Primary Tumors and Displaying Varying Metastatic ActivityPancreas, 2004
- Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancerOncogene, 2004
- The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic miceGastroenterology, 2001
- Hypermethylation of multiple genes in pancreatic adenocarcinoma.2000
- Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.1997